Burrows, 1999 - Google Patents

The Influence of Block Copolymers on Some Properties of Biodegradable Polymer Blends

Burrows, 1999

Document ID
10872106619327004912
Author
Burrows I
Publication year
Publication venue
PQDT-Global

External Links

Snippet

A novel series of biodegradable polymer blends based on high and low molecular weight polycaprolactone (Capa 680 and Capa 240) and the triblock copolymers Pluronic L61 and Pluronic F68 (poloxamers with a poly (ethylene oxide)-poly (propylene oxide)-poly (ethylene …
Continue reading at search.proquest.com (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A61K9/204—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION, OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
    • A61K47/30—Macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients

Similar Documents

Publication Publication Date Title
Wei et al. Development of 3D printed tablets by fused deposition modeling using polyvinyl alcohol as polymeric matrix for rapid drug release
US5919835A (en) Biodegradable polymer blends for drug delivery
Kohane et al. Biodegradable polymeric microspheres and nanospheres for drug delivery in the peritoneum
Ravi Kumar et al. Polymeric controlled drug-delivery systems: perspective issues and opportunities
Youxin et al. In-vitro degradation and bovine serum albumin release of the ABA triblock copolymers consisting of poly (L (+) lactic acid), or poly (L (+) lactic acid-co-glycolic acid) A-blocks attached to central polyoxyethylene B-blocks
Tamada et al. The development of polyanhydrides for drug delivery applications
Anderson et al. Biodegradation and biocompatibility of PLA and PLGA microspheres
Kim et al. Comparative study on sustained release of human growth hormone from semi-crystalline poly (L-lactic acid) and amorphous poly (D, L-lactic-co-glycolic acid) microspheres: morphological effect on protein release
AU2005299748B2 (en) In situ controlled release drug delivery system
Sinha et al. Bioabsorbable polymers for implantable therapeutic systems
JPS63118326A (en) Polyester containing block of alkylene oxide and its use as drug supply system
HUE031648T2 (en) Biodegradable multi-block co-polymers
Huatan et al. Preparation and characterization of poly (ε-caprolactone) polymer blends for the delivery of proteins
Çalış et al. Influence of irradiation sterilization on poly (lactide-co-glycolide) microspheres containing anti-inflammatory drugs
Le Devedec et al. Factors controlling drug release in cross-linked poly (valerolactone) based matrices
Abel et al. Amino acid-based poly (ester urea) s as a matrix for extended release of entecavir
AU766959B2 (en) Drug delivery of proteins from polymeric blends
Nassar et al. Fundamental advances in hydrogels for the development of the next generation of smart delivery systems as biopharmaceuticals
Bikiaris et al. Novel biodegradable polyester poly (propylene succinate): synthesis and application in the preparation of solid dispersions and nanoparticles of a water-soluble drug
Zignani et al. New generation of poly (ortho esters): synthesis, characterization, kinetics, sterilization and biocompatibility
Ng et al. In Vitro and In Vivo Hydrolytic Degradation Behaviors of a Drug-Delivery System Based on the Blend of PEG and PLA Copolymers
Burrows The Influence of Block Copolymers on Some Properties of Biodegradable Polymer Blends
Choi et al. Poly (ethylene glycol)–poly (l-lactide) diblock copolymer prevents aggregation of poly (l-lactide) microspheres during ethylene oxide gas sterilization
KR970002615B1 (en) Oral medical preparation with sustained release
Shih et al. Acid catalyzed poly (ortho ester) matrices for intermediate term drug delivery